COSCIENS Biopharma Inc. (TSX:CSCI)
Canada · Delayed Price · Currency is CAD 2.700
+0.010 (0.37%)
May 1, 2026, 3:59 PM EST
COSCIENS Biopharma Market Cap
COSCIENS Biopharma has a market cap or net worth of CAD 8.57 million as of May 1, 2026. Its market cap has decreased by -2.31% in one year.
Market Cap
8.57M
Enterprise Value
1.49M
Revenue
10.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.70
Market Cap Chart
Since April 22, 1996, COSCIENS Biopharma's market cap has decreased from 14.82B to 8.57M, a decrease of -99.94%. That is a compound annual growth rate of -21.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 8.57M | -5.25% |
| Dec 31, 2025 | 9.04M | 30.63% |
| Dec 31, 2024 | 6.92M | -44.54% |
| Dec 29, 2023 | 12.48M | -40.23% |
| Dec 30, 2022 | 20.88M | -62.20% |
| Dec 31, 2021 | 55.24M | 63.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rapid Dose Therapeutics | 12.96M |
| Innovotech | 11.98M |
| PreveCeutical Medical | 11.96M |
| Hemostemix | 11.87M |
| Marvel Biosciences | 10.40M |
| Glow Lifetech | 8.65M |
| PharmaTher Holdings | 7.74M |
| MindBio Therapeutics | 7.28M |